Dr. Aviv Regev

Dr. Aviv Regev is a computational and systems biologist who leads Genentech Research and Early Development (gRED), overseeing all aspects of the company's drug discovery and early development activities. She is a pioneer in single-cell and spatial genomics and a founding co-chair of the Human Cell Atlas. Prior to her role at Genentech, she held positions as a Professor of Biology at MIT and as a Core Member and Founding Director at the Broad Institute of MIT and Harvard.